SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-076409
Filing Date
2024-06-28
Accepted
2024-06-28 17:29:14
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2417839-4_s3.htm S-3 405036
2 EXHIBIT 4.3 tm2417839d5_ex4-3.htm EX-4.3 366617
3 EXHIBIT 5.1 tm2417839d5_ex5-1.htm EX-5.1 17172
4 EXHIBIT 5.2 tm2417839d5_ex5-2.htm EX-5.2 40815
5 EXHIBIT 23.3 tm2417839d5_ex23-3.htm EX-23.3 2370
6 EX-FILING FEES tm2417839d5_exfiling-fees.htm EX-FILING FEES 23292
7 GRAPHIC lg_kiniksa-4c.jpg GRAPHIC 41855
8 GRAPHIC tm2417839d5_ex5-1img001.jpg GRAPHIC 3770
9 GRAPHIC tm2417839d5_ex5-2img001.jpg GRAPHIC 14158
10 GRAPHIC tm2417839d5_ex5-2img002.jpg GRAPHIC 37233
  Complete submission text file 0001104659-24-076409.txt   990635
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280611 | Film No.: 241087080
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)